Company Filing History:
Years Active: 2001-2014
Title: Aldo Giannozzi: Innovator in Saccharide Conjugates
Introduction
Aldo Giannozzi is a notable inventor based in Siena, Italy. He has made significant contributions to the field of biochemistry, particularly in the development of modified saccharides and their applications in vaccines. With a total of 2 patents, Giannozzi's work has implications for improving immunogenicity in vaccine formulations.
Latest Patents
Giannozzi's latest patents include innovative technologies related to saccharide-protein conjugates. One of his patents describes a new type of linker for saccharide-protein conjugates, which enhances their immunogenic properties. The conjugates are prepared from modified saccharides that include a specific moiety, which is crucial for their effectiveness. His other patent focuses on a combined vaccine for bacterial meningitis, which incorporates Hib and MenC oligosaccharide conjugates, showcasing his commitment to advancing public health.
Career Highlights
Throughout his career, Aldo Giannozzi has worked with prominent companies in the pharmaceutical industry, including Chiron S.p.A. and Novartis AG. His experience in these organizations has allowed him to contribute to significant advancements in vaccine development and biochemistry.
Collaborations
Giannozzi has collaborated with esteemed colleagues such as Paolo Costantino and Francesco Norelli. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work.
Conclusion
Aldo Giannozzi's innovative contributions to the field of biochemistry, particularly in the area of saccharide conjugates, highlight his role as a key inventor. His patents and collaborations reflect a dedication to improving vaccine efficacy and public health.